Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
Celia J. A. Morgan, Tom P. Freeman, John Powell, et al.
Translational Psychiatry (2016) Vol. 6, Iss. 2, pp. e738-e738
Open Access | Times Cited: 98

Showing 1-25 of 98 citing articles:

Keep off the grass? Cannabis, cognition and addiction
H. Valerie Curran, Tom P. Freeman, Claire Mokrysz, et al.
Nature reviews. Neuroscience (2016) Vol. 17, Iss. 5, pp. 293-306
Open Access | Times Cited: 361
Etiology in psychiatry: embracing the reality of poly‐gene‐environmental causation of mental illness
Rudolf Uher, Alyson Zwicker
World Psychiatry (2017) Vol. 16, Iss. 2, pp. 121-129
Open Access | Times Cited: 282
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Robin M. Murray, Harriet Quigley, Diego Quattrone, et al.
World Psychiatry (2016) Vol. 15, Iss. 3, pp. 195-204
Open Access | Times Cited: 250
The neuropsychopharmacology of cannabis: A review of human imaging studies
Michael Bloomfield, Chandni Hindocha, Sebastian F Green, et al.
Pharmacology & Therapeutics (2018) Vol. 195, pp. 132-161
Open Access | Times Cited: 210
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Abigail M. Freeman, Kat Petrilli, Rachel Lees, et al.
Neuroscience & Biobehavioral Reviews (2019) Vol. 107, pp. 696-712
Open Access | Times Cited: 181
Cannabis-associated psychosis: Neural substrate and clinical impact
Robin M. Murray, Amir Englund, Anissa Abi‐Dargham, et al.
Neuropharmacology (2017) Vol. 124, pp. 89-104
Closed Access | Times Cited: 177
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
Celia J. A. Morgan, Tom P. Freeman, Chandni Hindocha, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 124
Gene–environment interplay in the etiology of psychosis
Alyson Zwicker, Eileen M. Denovan‐Wright, Rudolf Uher
Psychological Medicine (2018) Vol. 48, Iss. 12, pp. 1925-1936
Closed Access | Times Cited: 112
Cannabis Use and the Risk for Psychosis and Affective Disorders
Lucia Sideli, Harriet Quigley, Caterina La Cascia, et al.
Journal of Dual Diagnosis (2019) Vol. 16, Iss. 1, pp. 22-42
Closed Access | Times Cited: 111
Neuronal and molecular effects of cannabidiol on the mesolimbic dopamine system: Implications for novel schizophrenia treatments
Justine Renard, Christopher Norris, Walter J. Rushlow, et al.
Neuroscience & Biobehavioral Reviews (2017) Vol. 75, pp. 157-165
Closed Access | Times Cited: 88
Cannabis consumption and psychosis or schizophrenia development
María Bettina Ortiz-Medina, Marta Perea-Ortueta, Júlio Torales, et al.
International Journal of Social Psychiatry (2018) Vol. 64, Iss. 7, pp. 690-704
Closed Access | Times Cited: 85
Consensus paper of the WFSBP task force on cannabis, cannabinoids and psychosis
Deepak Cyril D’Souza, Marta Di Forti, Suhas Ganesh, et al.
The World Journal of Biological Psychiatry (2022) Vol. 23, Iss. 10, pp. 719-742
Closed Access | Times Cited: 63
Cognitive outcomes associated with long-term, regular, recreational cannabis use in adults: A meta-analysis.
Monica E. Lovell, Jane Akhurst, Christine Padgett, et al.
Experimental and Clinical Psychopharmacology (2019) Vol. 28, Iss. 4, pp. 471-494
Closed Access | Times Cited: 72
Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt/mTOR pathway
Inés Ibarra‐Lecue, Irene Mollinedo-Gajate, J. Javier Meana, et al.
Neuropsychopharmacology (2018) Vol. 43, Iss. 10, pp. 2028-2035
Open Access | Times Cited: 71
Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1–2 Phosphorylation
Roger Hudson, Justine Renard, Christopher Norris, et al.
Journal of Neuroscience (2019) Vol. 39, Iss. 44, pp. 8762-8777
Open Access | Times Cited: 71
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
Grace Blest‐Hopley, Marco Colizzi, Vincent Giampietro, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 66
Factors Moderating the Association between Cannabis Use and Psychosis Risk: A Systematic Review
Sanne J. van der Steur, Albert Batalla, Matthijs G. Bossong
Brain Sciences (2020) Vol. 10, Iss. 2, pp. 97-97
Open Access | Times Cited: 62
Rates and correlates of cannabis-associated psychotic symptoms in over 230,000 people who use cannabis
Tabea Schoeler, Jason Ferris, Adam Winstock
Translational Psychiatry (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 31
Cannabis Pharmacogenomics: A Path to Personalized Medicine
Mariana Babayeva, Zvi G. Loewy
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3479-3514
Open Access | Times Cited: 17
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
H. Valerie Curran, Chandni Hindocha, Celia J. A. Morgan, et al.
Psychological Medicine (2018) Vol. 49, Iss. 09, pp. 1574-1580
Open Access | Times Cited: 58
Cannabis and Psychosis: What Degree of Proof Do We Require?
Robin M. Murray, Marta Di Forti
Biological Psychiatry (2016) Vol. 79, Iss. 7, pp. 514-515
Closed Access | Times Cited: 52
Cannabis induced psychosis: A systematic review on the role of genetic polymorphisms
Cláudia Carvalho, Maria Augusta Vieira‐Coelho
Pharmacological Research (2022) Vol. 181, pp. 106258-106258
Open Access | Times Cited: 25
Aberrant salience in cannabis-induced psychosis: a comparative study
Valerio Ricci, Ilenia Di Muzio, Franca Ceci, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 5
Cannabis Use and Psychotic-Like Experiences: A Systematic Review of Biological Vulnerability, Potency Effects, and Clinical Trajectories
Valerio Ricci, Stefania Chiappini, Giovanni Martinotti, et al.
Psychiatry Research (2025), pp. 116496-116496
Closed Access
Cannabis use selectively modulates circulating biomarkers in the blood of schizophrenia patients
Inés Ibarra‐Lecue, Paula Unzueta‐Larrinaga, R. Barrena-Barbadillo, et al.
Addiction Biology (2022) Vol. 27, Iss. 6
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top